Genelux (GNLX) Free Cash Flow (2022 - 2026)
Genelux's (GNLX) quarterly Free Cash Flow came in at -$7.0 million in Q1 2026, down 27.72% year-on-year from -$9.7 million in Q1 2025, and down 5.2% quarter-over-quarter from -$6.6 million in Q4 2025.
Genelux (GNLX) Free Cash Flow (2022 - 2026) Analysis & Trends
Genelux's Free Cash Flow history runs 5 years deep, the most recent figure standing at -$7.0 million for Q1 2026.
- On a quarterly basis, Free Cash Flow fell 27.72% year-over-year to -$7.0 million in Q1 2026; TTM through Mar 2026 was -$27.9 million, a 22.88% decrease from a year earlier, with the FY2025 full-year figure at -$26.4 million, down 22.01% from the prior year.
- Free Cash Flow declined to -$7.0 million in Q1 2026 per GNLX's latest filing, from -$6.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $2.8 million in Q1 2022 and bottomed at -$7.2 million in Q2 2025.
- The 5-year median for Free Cash Flow is -$5.8 million (2024), against an average of -$5.0 million.
- Across the five-year window, Free Cash Flow plunged 371.21% in 2023 and jumped 38.52% in 2024, its largest moves.
- Year by year, Free Cash Flow stood at -$1.5 million in 2022, then plunged by 371.21% to -$7.2 million in 2023, then soared by 38.52% to -$4.4 million in 2024, then plunged by 50.86% to -$6.6 million in 2025, then retreated by 5.2% to -$7.0 million in 2026.
- Per Business Quant, the three latest GNLX Free Cash Flow figures stand at -$7.0 million (Q1 2026), -$6.6 million (Q4 2025), and -$7.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.95 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | -6.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.98 Mn |
| Mar 31, 2026 | -6.98 Mn |
| Dec 31, 2025 | -6.64 Mn |
| Dec 31, 2025 | -6.64 Mn |
| Sep 30, 2025 | -7.09 Mn |
| Sep 30, 2025 | -7.09 Mn |
| Jun 30, 2025 | -7.18 Mn |
| Jun 30, 2025 | -7.18 Mn |
| Mar 31, 2025 | -5.47 Mn |
| Mar 31, 2025 | -5.47 Mn |
| Dec 31, 2024 | -4.40 Mn |
| Dec 31, 2024 | -4.40 Mn |
| Sep 30, 2024 | -5.78 Mn |
| Sep 30, 2024 | -5.78 Mn |
| Jun 30, 2024 | -7.05 Mn |
| Jun 30, 2024 | -7.05 Mn |
| Mar 31, 2024 | -4.38 Mn |
| Mar 31, 2024 | -4.38 Mn |
| Dec 31, 2023 | -7.15 Mn |
| Dec 31, 2023 | -7.15 Mn |